Patients Discontinuing Anti-Obesity Jabs Gain Back Pounds at a Quadrupled Rate Compared to Dieters

New research suggests that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who stop traditional lifestyle regimens.

Published data in a major medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month after stopping.

"Individuals using such drugs need to be aware of the potential of quick weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of regain implies a return to pre-treatment mass in about a year and a half.

Analyzing Therapies

The analysis, which reviewed dozens of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with older methods.

Scientists point out that people who lose weight through lifestyle changes alone generally see a more gradual weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Doctors suggest the mechanism of the jabs explains the heightened weight return.

The injections imitate a natural hormone called glucagon-like peptide-1, which controls hunger.

"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making excessive eating much more probable."

An Ongoing Disease?

The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals argue that, considering the high risk of weight regain, the therapy is often long-term.

This view is supported by drug manufacturers, who say that the findings "emphasize the long-term character of obesity," similar to managing conditions like diabetes.

Patient Experiences

People who have come off the jabs explain a powerful resurgence of appetite.

"It was like something that goes on and you're instantly ravenous," said an individual.

This challenge is exacerbated if users have not adopted permanent lifestyle or habit modifications during therapy.

Significant Use

Survey data suggest that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.

• Adoption is higher among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• Many obtain the drugs through private prescriptions rather than public health services.

In conclusion, experts caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic solution and long-term success relies on integrated behavioural changes.